Receptor pair for schizophrenia

Pediatric Research

Volumn 64, Issue 1, 2008, Pages 1-

  Sealfon, Stuart C ^a   González Maeso, Javier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DOPAMINE; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; LYSERGIDE; MESCALINE; METABOTROPIC RECEPTOR 2; NEUROTRANSMITTER RECEPTOR; PSILOCYBINE; PSYCHEDELIC AGENT; RISPERIDONE; SEROTONIN; SEROTONIN 2A RECEPTOR; METABOTROPIC RECEPTOR; MULTIPROTEIN COMPLEX; NEUROLEPTIC AGENT;

DRUG MECHANISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOSIS; SCHIZOPHRENIA; SHORT SURVEY; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; NOTE;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; HALLUCINOGENS; HUMANS; MULTIPROTEIN COMPLEXES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 49849083284     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318180052a     Document Type: Short Survey

References (2)

1. Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC 2008 Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93-97
2. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD 2007 Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 13:1102-1107